Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro.
Saved in:
| Title: | Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro. |
|---|---|
| Authors: | Cuevas E; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. Elvis-Yane.Cuevas-Martinez@fda.hhs.gov., Rosas-Hernandez H; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Burks SM; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Ramirez-Lee MA; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Guzman A; Escuela Nacional Preparatoria-UNAM, Mexico, Mexico., Imam SZ; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Ali SF; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Sarkar S; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. |
| Source: | Metabolic brain disease [Metab Brain Dis] 2019 Oct; Vol. 34 (5), pp. 1365-1374. Date of Electronic Publication: 2019 Jul 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8610370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7365 (Electronic) Linking ISSN: 08857490 NLM ISO Abbreviation: Metab Brain Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31267346 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cuevas+E%22">Cuevas E</searchLink>; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. Elvis-Yane.Cuevas-Martinez@fda.hhs.gov.<br /><searchLink fieldCode="AU" term="%22Rosas-Hernandez+H%22">Rosas-Hernandez H</searchLink>; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA.<br /><searchLink fieldCode="AU" term="%22Burks+SM%22">Burks SM</searchLink>; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA.<br /><searchLink fieldCode="AU" term="%22Ramirez-Lee+MA%22">Ramirez-Lee MA</searchLink>; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA.<br /><searchLink fieldCode="AU" term="%22Guzman+A%22">Guzman A</searchLink>; Escuela Nacional Preparatoria-UNAM, Mexico, Mexico.<br /><searchLink fieldCode="AU" term="%22Imam+SZ%22">Imam SZ</searchLink>; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA.<br /><searchLink fieldCode="AU" term="%22Ali+SF%22">Ali SF</searchLink>; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA.<br /><searchLink fieldCode="AU" term="%22Sarkar+S%22">Sarkar S</searchLink>; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228610370%22">Metabolic brain disease</searchLink> [Metab Brain Dis] 2019 Oct; Vol. 34 (5), pp. 1365-1374. <i>Date of Electronic Publication: </i>2019 Jul 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8610370 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7365 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208857490%22">08857490 </searchLink><i>NLM ISO Abbreviation: </i>Metab Brain Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31267346 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11011-019-00447-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1365 Titles: – TitleFull: Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cuevas E – PersonEntity: Name: NameFull: Rosas-Hernandez H – PersonEntity: Name: NameFull: Burks SM – PersonEntity: Name: NameFull: Ramirez-Lee MA – PersonEntity: Name: NameFull: Guzman A – PersonEntity: Name: NameFull: Imam SZ – PersonEntity: Name: NameFull: Ali SF – PersonEntity: Name: NameFull: Sarkar S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2019 Oct Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1573-7365 Numbering: – Type: volume Value: 34 – Type: issue Value: 5 Titles: – TitleFull: Metabolic brain disease Type: main |
| ResultId | 1 |